Selected Publications

• article

  1. Sarcopenia as a Preoperative Risk Stratification Tool among Older Adults with Inflammatory Bowel Disease..  Advances in geriatric medicine and research.  6. 2024
  2. Risk of Kidney Failure in Patients With Inflammatory Bowel Disease Undergoing Colectomy: A Nationwide Cohort Study..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  2024
  3. Antibiotic use and inflammatory bowel disease: number needed to harm? Authors' reply..  Gut.  73:871-872. 2024
  4. Optimal Management of Refractory Crohn's Disease: Current Landscape and Future Direction..  Clinical and experimental gastroenterology.  75-86. 2024
  5. Older Adults With Inflammatory Bowel Disease Are at Higher Risk of Developing Antibodies to Infliximab..  Inflammatory bowel diseases.  2024
  6. Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden..  Journal of Crohn's & colitis.  17:1395-1409. 2023
  7. Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study..  The American journal of gastroenterology.  119:313-322. 2023
  8. Management Considerations for the Older Adult With Inflammatory Bowel Disease..  Gastroenterology & hepatology.  19:592-599. 2023
  9. Preoperative Risk Factors for Adverse Events in Adults Undergoing Bowel Resection for Inflammatory Bowel Disease: 15-Year Assessment of the American College of Surgeons National Surgical Quality Improvement Program..  The American journal of gastroenterology.  118:2230-2241. 2023
  10. Early Ileocecal Resection for Crohn's Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study..  Gastroenterology.  165:976-985.e3. 2023
  11. Colorectal Cancer Screening and Surveillance in the Geriatric Population..  Current gastroenterology reports.  25:141-145. 2023
  12. Managing the older adult with inflammatory bowel disease: is age just a number?.  Current opinion in gastroenterology.  39:268-273. 2023
  13. Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease..  Therapeutic advances in gastroenterology.  -. 2023
  14. Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study..  Gut.  72:663-670. 2023
  15. Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment..  Current treatment options in gastroenterology.  20:564-581. 2022
  16. Perioperative Management of Ulcerative Colitis: A Systematic Review..  Diseases of the colon and rectum.  65:S5-S19. 2022
  17. Sarcopenia as a Risk Prediction Tool in Inflammatory Bowel Disease..  Inflammatory bowel diseases.  28:1932-1933. 2022
  18. Post-operative prevention and monitoring of Crohn's disease recurrence..  Gastroenterology report.  -. 2022
  19. Letter: fighting the battle but losing the war-inflammatory bowel disease and venous thromboembolism. Authors' reply..  Alimentary pharmacology & therapeutics.  56:1427-1428. 2022
  20. Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply..  Alimentary pharmacology & therapeutics.  56:1213-1214. 2022
  21. Cancer in Inflammatory Bowel Disease..  Gastroenterology clinics of North America.  51:649-666. 2022
  22. Cost-effectiveness of Venous Thromboembolism Prophylaxis After Hospitalization in Patients With Inflammatory Bowel Disease..  Inflammatory bowel diseases.  28:1169-1176. 2022
  23. Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis..  Alimentary pharmacology & therapeutics.  56:1157-1167. 2022
  24. Sarcopenia in Inflammatory Bowel Diseases: Reviewing Past Work to Pave the Path for the Future..  Current treatment options in gastroenterology.  20:250-260. 2022
  25. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia..  Inflammatory bowel diseases.  28:855-861. 2022
  26. Editorial: safety in numbers-cycling of biologics does not increase risk of adverse outcomes..  Alimentary pharmacology & therapeutics.  55:1459-1460. 2022
  27. Endoscopic Balloon Dilation Is Cost-Effective for Crohn's Disease Strictures..  Digestive diseases and sciences.  67:5462-5471. 2022
  28. Aging and IBD: A New Challenge for Clinicians and Researchers..  Inflammatory bowel diseases.  28:126-132. 2022
  29. Safety and Efficacy of Anti-TNF Therapy in Older Adults With Ulcerative Colitis: A New Path Forward..  Gastroenterology.  162:1762-1764. 2021
  30. Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer..  Digestive diseases and sciences.  67:3693-3701. 2021
  31. Risk of corticosteroid treatment and hospitalization after checkpoint inhibitor and radiation therapy in patients with cancer..  Cancer.  128:819-827. 2021
  32. Impact of COVID-19 on residency choice: A survey of New York City medical students..  PloS one.  16:-. 2021
  33. Delivery risks and outcomes associated with grand multiparity..  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.  35:1-7716. 2021
  34. Factors associated with delayed enteral nutrition in the intensive care unit: a propensity score-matched retrospective cohort study..  The American journal of clinical nutrition.  114:295-302. 2021
  35. Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  20:e761-e769. 2021
  36. Connecting the Dots: IBD and Frailty..  Digestive diseases and sciences.  67:406-407. 2021
  37. Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months..  Digestive diseases and sciences.  67:4278-4286. 2021
  38. Predictors of households at risk for food insecurity in the United States during the COVID-19 pandemic..  Public health nutrition.  24:3929-3936. 2021
  39. Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19..  Digestive diseases and sciences.  66:4398-4405. 2021
  40. Increasing Prevalence of Frailty and Its Association with Readmission and Mortality Among Hospitalized Patients with IBD..  Digestive diseases and sciences.  66:4178-4190. 2021
  41. Prevalence and Risk Factors for Inappropriate Continuation of Proton Pump Inhibitors After Discharge From the Intensive Care Unit..  Mayo Clinic proceedings.  96:2550-2560. 2020
  42. Reply..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  18:3059-3060. 2020
  43. Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City..  The Journal of rheumatology.  48:454-462. 2020
  44. Disease Course and Outcomes of COVID-19 Among Hospitalized Patients With Gastrointestinal Manifestations..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  19:1402-1409.e1. 2020
  45. Fertility Impact of Initial Operation Type for Female Ulcerative Colitis Patients..  Inflammatory bowel diseases.  26:1368-1376. 2020
  46. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease..  Inflammatory bowel diseases.  26:1394-1400. 2020
  47. Inflammatory Bowel Disease Therapy and Venous Thromboembolism..  Current treatment options in gastroenterology.  18:462-475. 2020
  48. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD..  Digestive diseases and sciences.  66:3113-3123. 2020
  49. Age Is Just a Number-Frailty Associates With Outcomes of Patients With Inflammatory Bowel Disease..  Gastroenterology.  158:2041-2043. 2020
  50. Venous thromboembolism in inflammatory bowel disease..  World journal of gastroenterology.  26:1231-1241. 2020
  51. Novel peer-facilitated method to decrease burnout and enhance professional development: the READ-SG prospective cohort study..  Postgraduate medical journal.  96:361-364. 2020
  52. Endoscopic Algorithm for Management of Gastrointestinal Bleeding in Patients With Continuous Flow LVADs: A Prospective Validation Study..  Journal of cardiac failure.  26:324-332. 2019
  53. Factors Associated With Adherence to Helicobacter pylori Testing During Hospitalization for Bleeding Peptic Ulcer Disease..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  18:1091-1098.e1. 2019
  54. Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  18:1133-1141.e3. 2019
  55. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors..  Alimentary pharmacology & therapeutics.  49:564-571. 2019
  56. Low Rates of Screening for Celiac Disease Among Family Members..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  17:463-468. 2018
  57. Determinants of Patient Satisfaction in Celiac Disease Care..  Journal of clinical gastroenterology.  52:30-35. 2018
  58. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus..  Digestive diseases and sciences.  62:1216-1222. 2017
  59. Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma..  Cancer.  116:2655-64. 2010

Research Overview

• Gastroenterologist with subspecialty training in Inflammatory Bowel Disease (IBD) interested in improving outcomes for older patients with IBD. Research focus on Sarcopenia and Frailty in IBD. 

Principal Investigator on

• Optimal Preoperative Care for Older Adults with Inflammatory Bowel Disease (K76) - Resubmission - 1 2024 - 2029
• Sarcopenia as a Preoperative Risk Stratification Tool Among Older Adults with Inflammatory Bowel Disease 2022 - 2024
• GEMSSTAR

Co-Investigator on

Keywords

• Sarcopenia; Frailty; IBD

Available to Provide Advice to Those

• At different institutions (mentor and mentee are at different institutions) 
• At my institution (mentor and mentee at same institution but different research interests or departments) 

Available to be Contacted for

• Career (e.g. networking, how to get grants, how to publish, how to get tenure, how to start a geriatric specialty clinic) 
• Research (e.g. reviewing study design, specific aims, selecting instruments) 
• Work/Life Balance (e.g. counseling on job stress, dual-career households, self-care) 

Interest in Transdisciplinary Projects

• Yes, I have a specific transdisciplinary project in mind (active interest) 

Want Information on Interest Groups

• Yes 

Areas of Focus

• Aging and surgery
• Frailty and resilience
• Medications and pharmacology